Macromoltek is based in beautiful Austin, Texas and is comprised of a diverse and knowledgeable team of engineers and scientists. Our mission is to streamline the biopharmaceutical research process in order to make new discoveries quickly and efficiently. We are dedicated to finding solutions against a diverse set of diseases and targets.
The Leadership Team
Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational analysis, and computational approaches to complex scientific problems. Dr. Berrondo has authored over 10 peer-reviewed scientific articles in journals such as Proteins, JMB, and PLoS One. Since moving to Austin, TX, she has already made her mark, being voted Austin Magazine’s Woman of the Year in 2013, winning Austin Startup Week’s Founder of the Year in 2015, pitching as a semi-finalist in the Circular Board pitch competition in Houston (April 2016), and being featured in a recent article in Inc. magazine (2016).
Susana Kaufmann is a software and algorithmic expert, with over 25 years of experience as a senior developer. She has cross-industry experience in inter-platform software development and computer simulation in the petrochemical, combustion, pharmaceutical and financial sectors. Susana has many years of successful delivery in technology services, having managed a software consulting company. As Macromoltek’s CTO and co-founder, Susana has leveraged her deep knowledge of fluid dynamics in building the company’s advanced computational engine. Additionally, she has driven the development of Macromoltek’s database used for custom antibody design projects.
Brenda Medellin, Ph.D., is scientist and science communicator dedicated to therapeutics and diagnostics development. She has over 10 years of experience in interdisciplinary biological research. She obtained her BS in Chemistry, Bacteriology and Parasitology, during which she researched anti-microbials, participated in the development of a diagnostic immunoassays, and characterized biophysical properties of motor proteins. She earned her Ph.D. on biochemistry and structural biology at the University of Texas at Austin, where she developed a small molecule drug against brain cancer and characterized bacterial enzymes involved in bio-remediation.
Business Development Lead
Dr. Raminderpal Singh is a seasoned business development executive, with extensive experience in both the UK and the US. He is passionate about data and computational technologies. Dr. Singh earned his Ph.D. in the semiconductor industry in 1997. Over the next decade, he led teams building advanced technologies at IBM. In 2003, he was selected by EETimes as one of the top 13 most influential people in the semiconductor industry. In 2007, Dr. Singh transitioned to business development at IBM Research, where he initiated, negotiated, and closed several complex collaboration deals. Including leading the go-to-market for the IBM Watson Genomics Analytics program.
Quintin Tyrell Davis
Senior Scientific Software Engineer
Scientific Software Engineer, Project Manager
Scientific Software Engineer
Sayuri Monarrez Yesaki
Scientific Software Engineer
Scientific Software Developer
Estephanie Bernal Jimenez
Computational Antibody Engineer